Two Long Island students who spent the majority of their summer doing research in the Chemistry Lab of Professor Iwao Ojima at Stony Brook University, were selected as Grand Prize winners in the Team category of the Siemens Competition in Math, Science & Technology.
Johns Hopkins Children's Center has received a $946,000 grant from the Bill & Melinda Gates Foundation to design a system that visually tracks the behavior of the tuberculosis bacterium in the body and its response to current and new drug treatments.
Nasal colonization by Staphylococci is an important risk factor that predisposes carriers to nosocomial (hospital) infections. Researchers hope that a new compound may greatly reduce this layer of colonizing bacteria so that hospital patients will be less likely to experience serious MRSA infections.
University at Buffalo geologists are studying the surface characteristics of naturally occurring antimicrobial clays, including some clays from France, to determine why they are such effective killers of bacteria, including MRSA.
Of the roughly 368,600 patients treated in U.S. hospitals in 2005 for Methicillin-resistant staphylococcus aureus, or MRSA, one of every 20 (or 5 percent) died.
A new consumer fact sheet published by The Soap and Detergent Association (SDA) describes the safe, beneficial, and proper use of surface cleaning products and disinfectants. SDA's "Product Fact Sheet: Hard Surface Hygiene" is available at no cost on SDA's website, at www.cleaning101.com/house.
- Researchers at the Centers for Disease Control and Prevention stated that invasive infection with methicillin-resistant Staphylococcus aureus (MRSA) may be twice as common as previously thought and could have mortality rates that would exceed those attributed to HIV/AIDS, emphysema, or homicide, according to a paper published in the Journal of the American Medical Association. For those covering this news, PolyMedix makes available Dr. Eric McAllister, vice president of clinical development of PolyMedix.
Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) appears to be more prevalent than previously believed, affecting certain populations disproportionately and is being found more often outside of health care settings, according to a study in the October 17 issue of JAMA.
Putting bacteria on birth control could stop the spread of drug-resistant microbes, and researchers at the University of North Carolina at Chapel Hill have found a way to do just that.
Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (NIH) in Bethesda, MD, will speak on HIV/AIDS : Much Accomplished, Much to Do at the Uniformed Services University of the Health Sciences (USU) May 16 as part of the university's annual Research Week.
A Johns Hopkins study of adult patients admitted to The Johns Hopkins Hospital showed that patients who resided in nursing homes or other kinds of long-term care facilities at any time within the last six months were far more likely than other adult patients to carry or be infected with a drug-resistant superbug.
Staying in a room in the intensive care unit previously occupied by a patient with treatment-resistant bacteria may increase the odds of acquiring such bacteria, according to a report in the October 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Infection control experts at Johns Hopkins are sounding the alarm for vulnerable health care workers to be on the lookout for a more aggressive form of methicillin-resistant Staphylococcus aureus (MRSA), called community-acquired MRSA. MRSA infections are resistant to commonly used antibiotics, including oxacillin (Bactocil), penicillin and cephalexin (Keflex).
A new study shows that MRSA is the most common cause of skin and soft-tissue infections among patients presenting in emergency rooms across the country.
Researchers have designed a new molecule that selectively slashes bacterial cell membranes, leaving the microbes to leak and die. Such compounds could lead to new topical or intravenous antibiotics, or to self-sterilizing materials ranging from countertops to surgical gowns.
Government policies in Burma that restrict public health and humanitarian aid have created an environment where AIDS, drug-resistant tuberculosis, malaria and bird flu (H5N1) are spreading unchecked.
Researchers have uncovered how members of one family of antibiotics kill bacteria that make people sick. This knowledge may help drug developers make these antibiotics, which fight tuberculosis and meningitis, more effective against drug-resistant strains of bacteria.
Researchers have discovered that "Staph" bacteria use a protective golden armor to ward off the immune system, a finding with the potential to lead to new treatments for serious infections now increasingly resistant to standard antibiotics.
Rates of neonatal infections in hospital born babies are up to 20 times higher in developing countries than in industrialised countries, reveals a review.
To help further understanding about MRSA and all its complexities, Pfizer is sponsoring a media teleconference to be held on Oct. 20, 2004.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right